Browsing Category

Top Industry News

7422 posts

DCAT Summit at Lugano Recap: Innovation at the Foundation of Pharmaceutical Development & Manufacturing 
By

By
In the race to deliver medicines faster, the industry’s next leap forward is being built—literally—at the ground floor of development and manufacturing. At the DCAT Summit at Lugano, “Expedition Pharma:…

GSK CEO Emma Walmsley Stepping Down; CEO Designate Named 
By

By
GSK has announced that Luke Miels, current Chief Commercial Officer at GSK, has been appointed CEO Designate, succeeding Emma Walmsley, who will step down as CEO, effective at the end…

Amgen Investing $650 M To Expand Mfg in Puerto Rico 
By

By
Amgen has announced a $650-million expansion of the company’s biologics manufacturing facility in Juncos, Puerto Rico, the latest of a series of investments in the US.   In September (September 2025),…

AbbVie Breaks Ground on $70-M US Biologics R&D & Mfg Expansion 
By

By
AbbVie has announced the start of construction of a $70-million expansion at the AbbVie Bioresearch Center in Worcester, Massachusetts, which serves as a center of excellence for biologics research and…

Halozyme To Acquire Elektrofi in $900-M Deal  
By

By
Halozyme Therapeutics, a San Diego, California-based bio/pharmaceutical company, has agreed to acquire Elektrofi, a bio/pharmaceutical company with a microparticle technology for biologics, in a deal worth up to $900 million…

Supplier News: Catalent, Rovi, Veranova, Aptar, Rezon Bio, Ansa Biotechnologies & NextPharma 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Catalent, Laboratorios Farmacéuticos Rovi, Veranova, Aptar, Rezon Bio, Ansa Biotechnologies and NextPharma.   General * Catalent Opens New Global HQ in Tampa, FloridaBiologics Manufacturing *…

The DCAT Summit at Lugano Recap: Driving Value through Patient-Centricity in Drug Development and the Supply Chain 
By

By
Under the theme, “Expedition Pharma: Innovation from a Patient-First Perspective,” the DCAT Summit at Lugano, held June 4–5, 2025, in Lugano, Switzerland, underscored a message that cannot be ignored: Achieving…

Lilly To Build $6.5-Bn Small-Molecule API Mfg Site in US 
By

By
Eli Lilly and Company has announced plans to build a new $6.5-billion small-molecule active pharmaceutical product (API) manufacturing facility at Generation Park in Houston, Texas.   The planned synthetic medicine API…

Fujifilm Opens $3.2-Bn Biomanufacturing Facility 
By

By
Fujifilm Biotechnologies has opened its $3.2- billion commercial-scale cell-culture biomanufacturing site in Holly Springs, North Carolina.   The first phase of the planned $3.2-billion manufacturing site opens with a capacity of…

Pfizer To Acquire Metsera in $7.3-Bn Deal To Boost Obesity Drug Portfolio 
By

By
Pfizer has agreed to acquire Metsera, a  New York-based clinical-stage bio/pharmaceutical company focused on obesity and cardiometabolic diseases, in deal worth up to $7.3 billion ($4.9 billion upfront plus a…